Good raise. Directors getting involved too which is also a plus. Lets see what the next few months has in store now. No CR overhang to stop this from getting to 20c in the short term.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
